Sue Jin

ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1

Gui Gao, Anna Plaas, Vivian P. Thompson et al. · Journal of Biological Chemistry · 2004 · 192 citations · Full text

3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models

Michael Soth, Johannes C. Hermann, Calvin Yee et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text

Drug Target, Janus Kinases, Immunology +21

The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells

Kyung Song, Francisco X. Talamás, Rebecca T. Suttmann et al. · Molecular Immunology · 2009 · 62 citations

Inflammation, Cytokine, Inflammatory Cytokine Expression +14

Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome

Stephen M. Lynch, Javier DeVicente, Johannes C. Hermann et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 33 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +11

Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors

Saul Jaime‐Figueroa, Javier de Vicente, Johannes C. Hermann et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 32 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +7